Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing
Immunotherapy has made great strides in the treatment of lung cancer, but a significant proportion of patients still do not respond to treatment. Therefore, the identification of novel targets is crucial to improving the response to immunotherapy. The tumor microenvironment (TME) is a complex niche...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1148061/full |
| _version_ | 1797837928951447552 |
|---|---|
| author | Qianqian Xue Wenbei Peng Siyu Zhang Xiaoshan Wei Linlin Ye Zihao Wang Xuan Xiang Pei Zhang Qiong Zhou |
| author_facet | Qianqian Xue Wenbei Peng Siyu Zhang Xiaoshan Wei Linlin Ye Zihao Wang Xuan Xiang Pei Zhang Qiong Zhou |
| author_sort | Qianqian Xue |
| collection | DOAJ |
| description | Immunotherapy has made great strides in the treatment of lung cancer, but a significant proportion of patients still do not respond to treatment. Therefore, the identification of novel targets is crucial to improving the response to immunotherapy. The tumor microenvironment (TME) is a complex niche composed of diverse pro-tumor molecules and cell populations, making the function and mechanism of a unique cell subset difficult to understand. However, the advent of single-cell RNA sequencing (scRNA-seq) technology has made it possible to identify cellular markers and understand their potential functions and mechanisms in the TME. In this review, we highlight recent advances emerging from scRNA-seq studies in lung cancer, with a particular focus on stromal cells. We elucidate the cellular developmental trajectory, phenotypic remodeling, and cell interactions during tumor progression. Our review proposes predictive biomarkers and novel targets for lung cancer immunotherapy based on cellular markers identified through scRNA-seq. The identification of novel targets could help improve the response to immunotherapy. The use of scRNA-seq technology could provide new strategies to understand the TME and develop personalized immunotherapy for lung cancer patients. |
| first_indexed | 2024-04-09T15:33:39Z |
| format | Article |
| id | doaj.art-bc3f6ec03e1e48d2895a2dfefd01ee6f |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-09T15:33:39Z |
| publishDate | 2023-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-bc3f6ec03e1e48d2895a2dfefd01ee6f2023-04-28T05:16:23ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-04-011410.3389/fimmu.2023.11480611148061Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencingQianqian XueWenbei PengSiyu ZhangXiaoshan WeiLinlin YeZihao WangXuan XiangPei ZhangQiong ZhouImmunotherapy has made great strides in the treatment of lung cancer, but a significant proportion of patients still do not respond to treatment. Therefore, the identification of novel targets is crucial to improving the response to immunotherapy. The tumor microenvironment (TME) is a complex niche composed of diverse pro-tumor molecules and cell populations, making the function and mechanism of a unique cell subset difficult to understand. However, the advent of single-cell RNA sequencing (scRNA-seq) technology has made it possible to identify cellular markers and understand their potential functions and mechanisms in the TME. In this review, we highlight recent advances emerging from scRNA-seq studies in lung cancer, with a particular focus on stromal cells. We elucidate the cellular developmental trajectory, phenotypic remodeling, and cell interactions during tumor progression. Our review proposes predictive biomarkers and novel targets for lung cancer immunotherapy based on cellular markers identified through scRNA-seq. The identification of novel targets could help improve the response to immunotherapy. The use of scRNA-seq technology could provide new strategies to understand the TME and develop personalized immunotherapy for lung cancer patients.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1148061/fulllung cancertumor microenvironmentsingle-cell RNA sequencingimmune checkpoint blockadeimmunotherapy |
| spellingShingle | Qianqian Xue Wenbei Peng Siyu Zhang Xiaoshan Wei Linlin Ye Zihao Wang Xuan Xiang Pei Zhang Qiong Zhou Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing Frontiers in Immunology lung cancer tumor microenvironment single-cell RNA sequencing immune checkpoint blockade immunotherapy |
| title | Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing |
| title_full | Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing |
| title_fullStr | Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing |
| title_full_unstemmed | Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing |
| title_short | Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing |
| title_sort | promising immunotherapeutic targets in lung cancer based on single cell rna sequencing |
| topic | lung cancer tumor microenvironment single-cell RNA sequencing immune checkpoint blockade immunotherapy |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1148061/full |
| work_keys_str_mv | AT qianqianxue promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT wenbeipeng promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT siyuzhang promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT xiaoshanwei promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT linlinye promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT zihaowang promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT xuanxiang promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT peizhang promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing AT qiongzhou promisingimmunotherapeutictargetsinlungcancerbasedonsinglecellrnasequencing |